GSD[+] | GSD[−] (controls) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Characteristic | n | ISSNHL | PY | Rate | n | ISSNHL | PY | Rate@ | IRR (95% CI) | p Value |
All | 26 449 | 176 | 189 762.67 | 9.27 | 52 898 | 256 | 392 452.13 | 6.52 | 1.42 (1.17 to 1.72) | <0.01 |
Age (years) | ||||||||||
0–35 | 4408 | 10 | 33 771.12 | 2.96 | 8786 | 15 | 67 618.38 | 2.22 | 1.33 (0.60 to 2.97) | 0.48 |
35–49 | 7476 | 49 | 56 506.78 | 8.67 | 14 769 | 59 | 113 728.54 | 5.19 | 1.67 (1.14 to 2.44) | <0.01 |
50–64 | 7397 | 75 | 53 703.59 | 13.97 | 14 864 | 96 | 110 438.46 | 8.69 | 1.61 (1.19 to 2.17) | <0.01 |
≥65 | 7168 | 42 | 45 781.18 | 9.17 | 14 479 | 86 | 100 666.74 | 8.54 | 1.07 (0.74 to 1.55) | 0.71 |
Gender | ||||||||||
Male | 12 003 | 92 | 83 915.80 | 10.96 | 23 931 | 121 | 175 626.39 | 6.89 | 1.59 (1.21 to 2.09) | <0.01 |
Female | 14 446 | 84 | 105 846.87 | 7.94 | 28 967 | 135 | 216 825.73 | 6.23 | 1.27 (0.97 to 1.67) | <0.01 |
Comorbidity | ||||||||||
DM | 2685 | 26 | 17 290.34 | 15.04 | 5370 | 53 | 36 867.12 | 14.38 | 1.05 (0.65 to 1.67) | 0.85 |
HTN | 5832 | 49 | 38 574.89 | 12.70 | 11 837 | 87 | 82 499.32 | 10.55 | 1.20 (0.85 to 1.71) | 0.30 |
Hch | 1675 | 14 | 11 262.61 | 12.43 | 3300 | 24 | 22 701.60 | 10.57 | 1.18 (0.61 to 2.27) | 0.63 |
Follow-up years | ||||||||||
<1 | 26 449 | 24 | 25 973.96 | 9.24 | 52 898 | 30 | 52 645.13 | 5.70 | 1.62 (0.95 to 2.77) | 0.08 |
1–2 | 25 692 | 48 | 50 597.40 | 9.49 | 52 413 | 56 | 103 949.84 | 5.39 | 1.76 (1.20 to 2.59) | <0.01 |
3–4 | 24 959 | 41 | 47 716.27 | 8.59 | 51 532 | 59 | 98 902.66 | 5.97 | 1.44 (0.97 to 2.15) | 0.07 |
≥5 | 21 223 | 63 | 65 475.03 | 9.62 | 44 186 | 111 | 136 954.49 | 8.10 | 1.19 (0.87 to 1.62) | 0.28 |
@Rate: per 10 000 PY.
DM, diabetes mellitus; GSD[+]/[−], [with]/[without] gallstone disease; Hch, hypercholesterolaemia; HTN, hypertension; IRR, incidence rate ratio; ISSNHL, idiopathic sudden sensorineural hearing loss; PY, person-years.